Expanding Innovations Welcomes Timothy J. Scannell to Its Board of Directors

Expanding Innovations Welcomes New Board Member

In a significant move aimed at strengthening its leadership team, Expanding Innovations™, an emerging pioneer in expandable implant technology for spine surgery, has announced that it has appointed Timothy J. Scannell to its Board of Directors. This decision comes as Expanding Innovations continues to forge ahead in a competitive landscape, focusing on addressing critical clinical challenges faced by spine surgeons today.

Ron Sacher, the Executive Chairman of Expanding Innovations, expressed enthusiasm about Tim's joining the team. He remarked, "We are delighted to welcome Tim to our Board. His wealth of experience and insight aligns closely with our strategic goals. With his exceptional track record in leading top-tier medical technology organizations, especially during his time as President and Chief Operating Officer of Stryker Corporation, Tim is poised to bring invaluable contributions to our team. We are excited to collaborate with him as we navigate the promising opportunities that lie ahead and ensure continued growth for EI."

Timothy J. Scannell, who boasts over 30 years in the medical technology field, echoed this sentiment with gratitude. "It is an honor to join Expanding Innovations' Board. I have always admired the company’s mission and its dedication to innovation. I am eager to leverage my experience to foster EI’s success while delivering meaningful outcomes for our patients, employees, and shareholders," he stated.

About Timothy J. Scannell

Mr. Scannell's biography showcases his impressive career in the medical technology arena. As a former President and Chief Operating Officer at Stryker, he oversaw all commercial operations globally from 2018 to 2021. Prior to that role, he served as Group President for Stryker's MedSurg and Neurotechnology divisions over a decade. His leadership in these high-impact roles has equipped him with a deep understanding and foresight of market dynamics and trends in the medical device sector.

In addition to his recent appointment, Scannell also holds positions on the boards of several other companies, including Insulet Corporation and Novocure Limited. His involvement in these organizations exemplifies his commitment to driving innovation and strategy in the rapidly evolving medical landscape.

Scannell is a proud alumnus of the University of Notre Dame, holding degrees in Business Administration and Marketing as well as a Master of Business Administration.

About Expanding Innovations

Founded with a commitment to solving some of the toughest clinical issues in spine surgery, Expanding Innovations is at the forefront of developing groundbreaking implant technologies. The company's flagship product, the X-PAC® Expandable Interbody Cage, represents a significant advancement in surgical support. Traditional screw-based implants have limitations, and EI’s unique NON-SCREW-based expandable cage technology solves these problems by introducing a patented lift and lock expansion mechanism. This innovative approach not only enhances surgeons' tactile feedback but also ensures robust locking upon completion of implant expansion.

As the surgery landscape continues to evolve, Expanding Innovations has already implanted over 18,000 X-PAC cages. The company’s ongoing commitment to technological advancement is expected to lead to significant enhancements and expansions within the X-PAC portfolio scheduled for 2026.

For more information about Expanding Innovations and its products, you can visit ExpandingInnovations.com and connect with them on LinkedIn for the latest updates and news.